As blocking of the S100P/RAGE interaction is clinically beneficial for cancer therapy, blocking of S100P function may also be helpful in inhibiting osteoclast differentiation and activity in senile osteoporosis or osteolysis caused by bone metastasis of cancer cells. The gene discussed is S100P; the disease is osteoporosis.